Growth hormone deficiency following radiotherapy for orbital and parameningeal sarcomas

Pediatric Hematology and Oncology

Volumn 16, Issue 1, 1999, Pages 23-33

  Goddard, Andrea G ^a   Harris, S J ^a,b   Plowman, P N ^a   Savage, M O ^a   Kingston, J E ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Cranial irradiation; Growth hormone; Orbital and parameningeal sarcoma

Indexed keywords

ANTINEOPLASTIC AGENT; GROWTH HORMONE; HUMAN GROWTH HORMONE; MELPHALAN; OXANDROLONE;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; IMMUNORADIOMETRIC ASSAY; MALE; ORBIT CANCER; PARAMENINGEAL DISORDER; RADIATION DOSE; RADIOIMMUNOASSAY; SARCOMA; SKULL IRRADIATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; EYE NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MENINGEAL NEOPLASMS; RADIOTHERAPY; RHABDOMYOSARCOMA; SARCOMA;

EID: 0032925899     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/088800199277560     Document Type: Article

References (36)

1. Shalet SM, Beardwell CG, Pearson D, Jones PH. The effect of varying doses of cerebral irradiation on growth hormone production in childhood. Clin Endocrinol (Oxf). 1976;5:287-290.
2. Littley MD, Shalet SM, Beardwell CG, Robinson EL, Sutton ML. Radiation-induced hypopituitarism is dose-dependent. Clin Endocrinol (Oxf). 1989;31:363-373.
3. Rappaport R, Brauner R. Growth and endocrine disorders secondary to cranial irradiation. Pediatr Res. 1989;25:561-567.
4. Talvensaari KK, Knip M, Lanning P, Lanning M. Clinical characteristics and factors affecting growth in long-term survivors of cancer. Med Pediatr Oneol. 1996;26:166-172.
5. Brauner R, Czernichow P, Rappaport R. Greater susceptibility to hypothalamopituitary irradiation in younger children with acute lymphoblastic leukemia [letter]. J Pediatr. 1986;108:332.
6. Kirk JA, Raghupathy P, Stevens MM, et al. Growth failure and growth-hormone deficiency after treatment for acute lymphoblastic leukaemia. Lancet. 1987;1:190-193.
7. Davies HA, Didcock E, Didi M, Ogilvy-Stuart A, Wales JK, Shalet SM. Growth, puberty and obesity after treatment for leukaemia. Acta Paediat Suppl. 95;411:45-50; discussion 51.
8. Ogilvy-Stuart AL, Shalet SM. Growth and puberty after growth hormone treatment after irradiation for brain tumours. Arch Dis Child. 1995;73:141-146.
9. Olshan JS, Gubernick J, Packer RJ, GJ D'Angio, Goldwein JW, Willi SM, Moshang TJr. The effects of adjuvant chemotherapy on growth in children with medulloblastoma. Cancer. 1992;70:2013-2017.
10. Ogilvy-Stuart AL, Shalet SM. Effect of chemotherapy on growth. Acta Paediatr Suppl. 1995;411:52-56.
11. Sulmont V, Brauner R, Fontoura M, Rappaport R. Response to growth hormone treatment and final height after cranial or craniospinal irradiation. Acta Paedialr Scand. 1990;79:542-549.
12. Brauner R, Rappaport R, Prevot C, et al. A prospective study of the development of growth hormone deficiency in children given cranial irradiation, and its relation to statural growth. J Clin Endocrinol Metah. 1989;68:346-351.
13. Sklar CA. Growth and neuroendocrine dysfunction following therapy for childhood cancer. Pediatr Clin North Am. 1997;44:489-503.
14. Cuneo RC, Salomon F, McGauley GA, Sonksen PH. The growth hormone deficiency syndrome in adults. Clin Endocrinol (Oxf). 1992;37:387-397.
15. Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990;336:285-288.
16. Shalet SM. Growth hormone deficiency and replacement in adults [editorial] [see comments]. BMJ. 1996;313:314.
17. Lannering B, Marky I, Mellander L, Albertsson-Wikland K. Growth hormone secretion and response to growth hormone therapy after treatment for brain tumour. Acta Paediatr Scand Suppl. 1988;343:146-151.
18. Huma Z, Boulad F, Black P, Heller G, Sklar C. Growth in children after bone marrow transplantation for acute leukemia. Blood. 1995;86:819-824.
19. Brauner R, Adan L, SouberbielleJC, et al. Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation. J Pediatr. 1997;130:785-792.
20. Heyn R, Ragab A, Raney RB Jr, et al. Late effects of therapy in orbital rhabdomyosarcoma in children a report from the Intergroup Rhabdomyosarcoma Study Cancer. 1986;57:1738-1743.
21. Bajorunas DR, Ghavimi F, Jereb B, Sonenberg M. Endocrine sequelae of antineoplastic therapy in childhood head and neck malignancies. J Clin Endocrinol Metab. 1980;50:329-335.
22. Raney B, Tefft M, Heyn R, et al. Ascending myelitis after intensive chemotherapy and radiation therapy in children with cranial parameningeal sarcoma. Cancer. 1992;69:1498-1506.
23. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965, II. Arch Dis Child. 1966;41:613-635.
24. Marshall WA, TannerJM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969;44:291-303.
25. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970;45:13-23.
26. Blacklay A, Grossman A, Ross RJ, et al. Cranial irradiation for cerebral and nasopharyngeal tumours in children: evidence for the production of a hypothalamic defect in growth hormone release. J Endocrinol. 1986;108:25-29.
27. Constine LS, Woolf PD, Cann D, et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors [published erratum appears in N Engl J Med. Apr 22, 1993; 328:1208] [see comments]. N Engl JMed. 1993;328:87-94.
28. Constine LS, Woolf PD, Cann D, et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors [published erratum appears in N Engl J Med. Apr 22, 1993; 328:1208] [see comments]. N Engl JMed. 1993;328:87-94.
29. Littley MD, Shalet SM, Beardwell CG. Radiation and hypothalamic-pituitary function. Baillieres Clin Endocrinol Mftab. 1990;4:147-175.
30. Wallace WH, Shalet SM. Chemotherapy with actinomycin D influences the growth of the spine following abdominal irradiation [letter]. Med Pediatr Oncol .1992;20:177.
31. Hindmarsh PC, Swift PG. An assessment of growth hormone provocation tests. Arch Dm Child. 1995;72: 362-367; discussion 367-368.
32. Tillmann V, Buckler JM, Kibirige MS, et al. Biochemical tests in the diagnosis of childhood growth hormone deficiency. J Clin Endocrinol Metab. 1997;82:531-535.
33. Cowell CT, Quigley CA, Moore B, et al. Growth and growth hormone therapy of children treated for leukaemia. Acta Paediatr Scand Supll. 1988;343:152-161.
34. Adan L, SouberbielleJC, ZuckerJM, Pierre-Kahn A, Kalifa C. Brauner R. Adult height in 24 patients treated for growth hormone deficiency and early puberty. J Clin Endocrinol Metab. 1997;82:229-233.
35. Adan L, Souberbielle JC, Blanche S, Leverger G, Schaison G, Brauner R. Adult height after cranial irradiation with 24 Gy: factors and markers of height loss. Acta Paediatr. 1996;85:1096-1101.
36. Carel JC, TrescaJP, Letrait M, et al. Growth hormone testing for the diagnosis of growth hormone deficiency in childhood: a population register-based study. J Clin Endocrinol Metab. 1997;82:2117-2121.